Butalbital And Acetaminophen Tablet
Product Images NDC 68682-306

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Butalbital And Acetaminophen (NDC 68682-306). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Butalbital-structure.jpg (Butalbital Structure)

Chemical structure diagram of Butalbital showing its molecular formula (C11H16N2O3) and molecular weight (224.26). The diagram illustrates the ring structure with attached functional groups.*

FDA Label Image

Apap Molecule (F68de00f 9150 4620 8e66 A319284ab192 02)

Chemical structure of acetaminophen, showing a benzene ring with hydroxyl (OH) and amide (NH-CO-CH3) functional groups.*

FDA Label Image

Label

Butalbital and Acetaminophen tablets 50 mg/300 mg oral tablets in a carton labeled by Oceanside Pharmaceuticals. The label states each tablet contains 50 mg Butalbital and 300 mg Acetaminophen, with a warning about habit-forming potential. The package contains 100 tablets. Additional information on dosage, storage, and distribution by Oceanside Pharmaceuticals, a division of Bausch Health US, LLC, is included alongside a barcode and revision date 04/2020.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.